Swiss National Bank decreased its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 4.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,391,188 shares of the healthcare conglomerate’s stock after selling 176,600 shares during the quarter. UnitedHealth Group comprises approximately 0.9% of Swiss National Bank’s investment portfolio, making the stock its 15th biggest holding. Swiss National Bank owned about 0.36% of UnitedHealth Group worth $827,484,000 at the end of the most recent quarter.
Other large investors have also modified their holdings of the company. Geode Capital Management LLC grew its position in shares of UnitedHealth Group by 9.1% in the fourth quarter. Geode Capital Management LLC now owns 11,593,401 shares of the healthcare conglomerate’s stock valued at $2,882,988,000 after purchasing an additional 965,763 shares in the last quarter. Foresters Investment Management Company Inc. grew its position in shares of UnitedHealth Group by 63.2% in the fourth quarter. Foresters Investment Management Company Inc. now owns 126,420 shares of the healthcare conglomerate’s stock valued at $31,494,000 after purchasing an additional 48,950 shares in the last quarter. Polar Capital LLP lifted its holdings in UnitedHealth Group by 0.3% in the fourth quarter. Polar Capital LLP now owns 490,705 shares of the healthcare conglomerate’s stock valued at $122,244,000 after acquiring an additional 1,500 shares during the last quarter. LMR Partners LLP acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $1,780,000. Finally, Stamos Capital Partners L.P. acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $2,242,000. Institutional investors own 85.65% of the company’s stock.
A number of research analysts recently commented on the company. Raymond James upped their price objective on UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a report on Friday, July 19th. UBS Group assumed coverage on UnitedHealth Group in a report on Tuesday, April 23rd. They issued a “neutral” rating and a $238.00 price objective on the stock. Citigroup upgraded UnitedHealth Group from a “neutral” rating to a “buy” rating and upped their price objective for the company from $247.00 to $280.00 in a report on Friday, May 10th. Cantor Fitzgerald set a $310.00 price objective on UnitedHealth Group and gave the company a “buy” rating in a report on Friday, July 19th. Finally, Royal Bank of Canada set a $311.00 price objective on UnitedHealth Group and gave the company a “buy” rating in a report on Friday, July 19th. One analyst has rated the stock with a sell rating, one has issued a hold rating and eighteen have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $295.06.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, topping analysts’ consensus estimates of $3.46 by $0.14. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The company had revenue of $60.60 billion for the quarter, compared to analysts’ expectations of $60.59 billion. During the same period in the prior year, the firm earned $3.14 earnings per share. The firm’s revenue was up 8.0% compared to the same quarter last year. On average, research analysts forecast that UnitedHealth Group Inc will post 14.84 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be paid a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a yield of 1.76%. The ex-dividend date of this dividend is Friday, September 13th. UnitedHealth Group’s dividend payout ratio (DPR) is 33.54%.
In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 12,000 shares of the company’s stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the transaction, the director now directly owns 61,309 shares in the company, valued at $15,652,800.79. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard T. Burke sold 5,000 shares of the company’s stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $246.40, for a total value of $1,232,000.00. Following the transaction, the director now owns 187,979 shares in the company, valued at $46,318,025.60. The disclosure for this sale can be found here. Insiders have sold 37,000 shares of company stock worth $9,195,620 over the last 90 days. 0.87% of the stock is owned by insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: What is the Coverage Ratio?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.